Total Payments
$5,126
2024 Payments
$497.08
Companies
23
Transactions
112
Medicare Patients
1,470
Medicare Billing
$102,241
Payment Breakdown by Category
Food & Beverage$5,126 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,126 | 112 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| BIOTISSUE HOLDINGS INC. | $671.96 | 10 | $0 (2024) |
| Glaukos Corporation | $454.56 | 6 | $0 (2023) |
| Aerie Pharmaceuticals, Inc. | $437.05 | 10 | $0 (2021) |
| Alcon Vision LLC | $405.29 | 10 | $0 (2023) |
| Alcon Laboratories Inc | $383.50 | 7 | $0 (2018) |
| NEW WORLD MEDICAL,INC. | $349.26 | 2 | $0 (2024) |
| TissueTech, Inc. | $337.24 | 5 | $0 (2019) |
| Shire North American Group Inc | $326.56 | 11 | $0 (2019) |
| Allergan, Inc. | $302.29 | 12 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $255.28 | 15 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $497.08 | 5 | NEW WORLD MEDICAL,INC. ($199.65) |
| 2023 | $1,096 | 13 | BIOTISSUE HOLDINGS, INC. ($344.14) |
| 2022 | $891.35 | 19 | GLAUKOS CORPORATION ($181.49) |
| 2021 | $313.61 | 11 | Aerie Pharmaceuticals, Inc. ($168.71) |
| 2020 | $265.03 | 10 | Aerie Pharmaceuticals, Inc. ($150.18) |
| 2019 | $735.92 | 17 | TissueTech, Inc. ($179.79) |
| 2018 | $654.04 | 19 | Alcon Laboratories Inc ($254.85) |
| 2017 | $673.71 | 18 | Alcon Laboratories Inc ($128.65) |
All Payment Transactions
112 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/27/2024 | NEW WORLD MEDICAL,INC. | Kahook Dual Blade (Device), Clearpath, Ahmed Glaucoma Valve | Food and Beverage | In-kind items and services | $199.65 | General |
| Category: Ophthalmology | ||||||
| 07/22/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $44.17 | General |
| 03/18/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | In-kind items and services | $123.90 | General |
| 01/31/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | Cash or cash equivalent | $121.52 | General |
| Category: Ophthalmology | ||||||
| 01/29/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | In-kind items and services | $7.84 | General |
| 11/08/2023 | NEW WORLD MEDICAL,INC. | — | Food and Beverage | In-kind items and services | $149.61 | General |
| 10/18/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $124.97 | General |
| Category: TEPEZZA | ||||||
| 10/16/2023 | AbbVie Inc. | LUMIGAN (Drug), ALPHAGAN P | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: EYE CARE | ||||||
| 09/27/2023 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $149.94 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/29/2023 | BIOTISSUE HOLDINGS, INC. | PROKERA (Device), AMNIOGRAFT | Food and Beverage | In-kind items and services | $23.63 | General |
| Category: HUMAN TISSUE PRODUCTS | ||||||
| 05/11/2023 | Glaukos Corporation | — | Food and Beverage | Cash or cash equivalent | $149.84 | General |
| 04/02/2023 | BIOTISSUE HOLDINGS, INC. | PROKERA (Device), AMNIOGRAFT | Food and Beverage | In-kind items and services | $175.96 | General |
| Category: HUMAN TISSUE PRODUCTS | ||||||
| 03/08/2023 | AbbVie Inc. | VUITY (Drug), LUMIGAN, ALPHAGAN P | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: EYE CARE | ||||||
| 02/27/2023 | Alcon Vision LLC | Simbrinza (Drug) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: Ophthalmology | ||||||
| 02/23/2023 | Alcon Vision LLC | HYDRUS Microstent (Device) | Food and Beverage | In-kind items and services | $102.54 | General |
| Category: Ophthalmology | ||||||
| 02/10/2023 | Alcon Vision LLC | Simbrinza (Drug) | Food and Beverage | In-kind items and services | $24.07 | General |
| Category: Ophthalmology | ||||||
| 01/23/2023 | BIOTISSUE HOLDINGS, INC. | PROKERA (Device), AMNIOGRAFT | Food and Beverage | In-kind items and services | $123.14 | General |
| Category: HUMAN TISSUE PRODUCTS | ||||||
| 01/23/2023 | BIOTISSUE HOLDINGS, INC. | PROKERA (Device), AMNIOGRAFT | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: HUMAN TISSUE PRODUCTS | ||||||
| 12/13/2022 | GLAUKOS CORPORATION | — | Food and Beverage | Cash or cash equivalent | $21.50 | General |
| Category: CORNEAL HEALTH | ||||||
| 12/12/2022 | GLAUKOS CORPORATION | ISTENT INJECT W (Device) | Food and Beverage | Cash or cash equivalent | $26.45 | General |
| Category: GLAUCOMA | ||||||
| 09/29/2022 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $20.60 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/07/2022 | GLAUKOS CORPORATION | ISTENT INJECT W (Device) | Food and Beverage | Cash or cash equivalent | $127.71 | General |
| Category: GLAUCOMA | ||||||
| 09/07/2022 | GLAUKOS CORPORATION | ISTENT INJECT W (Device) | Food and Beverage | Cash or cash equivalent | $5.83 | General |
| Category: GLAUCOMA | ||||||
| 09/01/2022 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $23.45 | General |
| Category: SOLUTION/ DROPS | ||||||
| 08/11/2022 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 166 | 177 | $28,775 | $10,713 |
| 2022 | 8 | 431 | 474 | $73,230 | $29,162 |
| 2021 | 8 | 453 | 482 | $76,575 | $32,292 |
| 2020 | 7 | 420 | 458 | $72,730 | $30,074 |
Total Patients
1,470
Total Services
1,591
Medicare Billing
$102,241
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Office | 2023 | 90 | 90 | $15,750 | $6,181 | 39.2% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 30 | 41 | $4,920 | $2,087 | 42.4% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 29 | 29 | $6,235 | $2,083 | 33.4% |
| 92133 | Imaging of optic nerve | Office | 2023 | 17 | 17 | $1,870 | $360.91 | 19.3% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 169 | 176 | $30,800 | $13,856 | 45.0% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 88 | 88 | $18,920 | $7,243 | 38.3% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 53 | 81 | $9,720 | $4,468 | 46.0% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 31 | 33 | $4,950 | $1,503 | 30.4% |
| 92133 | Imaging of optic nerve | Office | 2022 | 47 | 47 | $5,170 | $1,201 | 23.2% |
| 92134 | Imaging of retina | Office | 2022 | 13 | 16 | $1,920 | $414.16 | 21.6% |
| 92020 | Exam of the internal drainage system of eye | Office | 2022 | 16 | 19 | $1,330 | $368.96 | 27.7% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2022 | 14 | 14 | $420.00 | $107.25 | 25.5% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 178 | 185 | $32,375 | $14,925 | 46.1% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2021 | 110 | 110 | $23,650 | $10,445 | 44.2% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2021 | 38 | 54 | $6,480 | $3,354 | 51.8% |
| 92083 | Measurement of field of vision during daylight conditions, extended examination | Office | 2021 | 31 | 33 | $4,950 | $1,410 | 28.5% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2021 | 50 | 52 | $5,720 | $1,226 | 21.4% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 15 | 16 | $1,920 | $516.18 | 26.9% |
| 92020 | Examination of cornea and iris using lens device and slit lamp | Office | 2021 | 12 | 13 | $910.00 | $259.21 | 28.5% |
| 76514 | Ultrasound of corneal structure and measurement | Office | 2021 | 19 | 19 | $570.00 | $156.51 | 27.5% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2020 | 206 | 212 | $37,100 | $17,429 | 47.0% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2020 | 64 | 64 | $13,760 | $5,553 | 40.4% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2020 | 38 | 63 | $7,560 | $3,376 | 44.7% |
| 92083 | Measurement of field of vision during daylight conditions | Office | 2020 | 40 | 43 | $6,450 | $1,864 | 28.9% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2020 | 35 | 36 | $3,960 | $888.23 | 22.4% |
About Dr. David Abrams, MD
Dr. David Abrams, MD is a Ophthalmology healthcare provider based in San Antonio, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1881654341.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Abrams, MD has received a total of $5,126 in payments from pharmaceutical and medical device companies, with $497.08 received in 2024. These payments were reported across 112 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($5,126).
As a Medicare-enrolled provider, Abrams has provided services to 1,470 Medicare beneficiaries, totaling 1,591 services with total Medicare billing of $102,241. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location San Antonio, TX
- Active Since 03/27/2006
- Last Updated 07/08/2007
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1881654341
Products in Payments
- PROKERA (Device) $496.05
- XIIDRA (Drug) $407.15
- Prokera (Device) $337.24
- rocklatan (Drug) $244.53
- ACTIVEFOCUS (Device) $217.46
- Kahook Dual Blade (Device) $199.65
- Zioptan (Drug) $170.59
- ISTENT INJECT W (Device) $159.99
- EYLEA HD (Biological) $149.94
- Cequa (Drug) $149.01
- DURYSTA (Drug) $148.98
- ARGOS (Device) $124.99
- TEPEZZA (Drug) $124.97
- LUMIGAN (Drug) $124.61
- ISTENT TRABECULAR MICRO-BYPASS STENT SYSTEM (Device) $123.23
- Syfovre (Drug) $121.52
- rhopressa (Drug) $115.61
- LenSx (Device) $107.70
- CIRRUS HD-OCT (Device) $105.00
- OZURDEX (Drug) $104.59
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in San Antonio
Michael Singer, M.d, M.D
Ophthalmology — Payments: $2.0M
Ophthalmology $2.0M
Dr. Gregory Parkhurst, M.d, M.D
Ophthalmology — Payments: $399,485
Ophthalmology $399,485
Dr. James Lehmann, Md, MD
Ophthalmology — Payments: $328,572
Ophthalmology $328,572
Richard Evans, M.d, M.D
Ophthalmology — Payments: $116,394
Ophthalmology $116,394
Kenneth Maverick, M.d, M.D
Ophthalmology — Payments: $56,412
Ophthalmology $56,412
Kundandeep Nagi, M.d, M.D
Ophthalmology — Payments: $40,313
Ophthalmology $40,313